{% extends "layout.html" %}
  
{% block title %}Design{% endblock %}
{% block lead %}Hardware in iGEM should make synthetic biology based on standard parts easier, faster, better, or more accessible to our community.{% endblock %}

{% block page_content %}
<div class="standard-header banner-v1 curvy-divider">
    <h1> Design </h1>
    <div class="simple-wave-divider">
        <svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1200 120" preserveAspectRatio="none">
            <path d="M985.66,92.83C906.67,72,823.78,31,743.84,14.19c-82.26-17.34-168.06-16.33-250.45.39-57.84,11.73-114,31.07-172,41.86A600.21,600.21,0,0,1,0,27.35V120H1200V95.8C1132.19,118.92,1055.71,111.31,985.66,92.83Z" class="shape-fill"></path>
        </svg>
    </div>
</div>

<div class="d-flex flex-row mx-4 body-padding">
    <div class="fixed-index">
        <p>FIXED INDEX will go here once styled</p>
    </div>
    <div class="d-flex flex-column">
        <div class="container">
            <div class="wrapper pt-5 mt-5">
                <h2> How does an LFA Work? </h2>
                <p>Lateral flow assays (LFAs) use a series of antibodies to detect whether a biomarker is present in a liquid sample.</p> 

                <div class="diagram">
                    <p>
                        First, a sample is dropped onto the sample pad, which is designed to prepare the sample for optimum flow through the rest of the test strip. 
                        The sample flows through to the conjugate release pad that then is absorbed by the test membrane. Antibodies suspended on the conjugate pad bind to a biomarker in the sample. 
                        This primary antibody is labeled with nanoparticles that allow these antibodies to be detected with the naked eye.
                        If the molecule of interest is in the sample, these labeled primary antibodies bind to the molecule and ensure it will be seen later in the test.
                        The target molecule/labeled antibody complexes travel onto a nitrocellulose membrane, where two more antibodies are immobilized in lines.
                        Complexes reach the test line first, where another primary antibody targeting the molecule of interest is situated.
                        The target molecule binds this other primary antibody, and the whole complex becomes immobilized at the test line, forming a “sandwich complex”.
                        The labeled antibodies show up as a colored line, signaling detection of the target molecule.
                        The labeled antibody is unable to bind to the test line if the biomarker is not present in the sample.Regardless of whether the target molecule is in the sample, the labeled antibody continues down the nitrocellulose membrane and reaches the control line.
                        Here, a secondary antibody that binds to the labeled antibody itself is immobilized.
                        If the test is working properly, the secondary and labeled antibody will bind, causing the control line to show a colored line.
                        The sample continues off the membrane and is absorbed by an absorbent pad, stopping the fluid flow.
                    </p>
                </div>
                     

                <div class="diagram">
                    <p>
                        The sample is first applied to the sample pad, which is designed to prepare the sample for optimum flow through the rest of the test strip. Second, the sample flows from the sample pad to the conjugate pad, introducing a primary antibody specific to the molecule of interest suspended on the conjugate pad into the sample. 
                        This primary antibody is labeled with nanoparticles that allow these antibodies to be detected with the naked eye. If the molecule of interest is in the sample, these labeled primary antibodies bind to the molecule and ensure it will be seen later in the test. Next, the target molecule/labeled antibody complexes travel onto a nitrocellulose membrane, where two more antibodies are immobilized in lines. 
                        The complexes reach the test line first, where another primary antibody targeting the molecule of interest is bound. The target molecule binds this other primary antibody, and the whole complex becomes immobilized at the test line as well. The labeled antibodies show up as a colored line, allowing the entire "sandwich complex" to be detected and confirming the presence of the target molecule. If the target molecule is not in the sample, the labeled antibody is unable to bind to the test line. Regardless of whether the target molecule is in the sample, the labeled antibody continues down the nitrocellulose membrane and reaches the control line. 
                        At the control line, a secondary antibody that binds to the labeled antibody itself (rather than the molecule of interest) is immobilized, and if the test is working properly, will bind the labeled antibody, causing the control line to show up as colored. 
                        The sample continues off the membrane and is absorbed by an absorbent pad, stopping the fluid flow.
                    </p>
                </div>
                <p>We designed our LFA following the general pattern outlined above. First, we decided to test for the presence of oxidized low density lipoprotein (oxLDL) because oxLDL is a biomarker of atherosclerosis found in the blood (changing landscape of atherosclerosis, 2020). Then, if our test detected oxLDL, the patient would have evidence they are experiencing atherosclerosis. To detect oxLDL, we designed two primary antibodies. The labeled primary antibody bound to a protein component of oxLDL called MDA-modified apolipoprotein B (apoB-subscript MDA), while the other primary antibody immobilized at the test line bound to oxidized phospholipids within oxLDL. The fact that these two primary antibodies bound to different epitopes on oxLDL helped ensure the antibodies did not interfere with each other binding. Lastly, we designed a secondary antibody targeting the constant domain of the labeled primary antibody and used this on the control line to verify the test worked correctly.</p>
            </div>
        </div>

        <div class="container body-section">
            <div class="wrapper">
                <h2>Choosing a Chassis</h2>
                <p>
                    Our LFA requires the production of three different antibodies/antibody fragments, and we wanted to produce these antibodies by using bacteria. Most bacteria, like E. coli, can only produce the disulfide bonds necessary for antibody production in their periplasm. However, one group of scientists developed a strain of E. coli with a more oxidizing cytoplasm that is able to form disulfide bonds, and this strain is SHuffle. All of our antibodies and antibody fragments have disulfide bonds and the number of cysteines fall within the optimal range of our choice, the B strain of E. coli SHuffle. 
                </p>
            </div>
        </div>
        <div class="container body-section">
            <h2>Plasmid Design</h2>
            <p>Overall summary of how plasmids were designed, why they were designed the way they were, parts used. How the synthesized fragments were obtained and put into backbone (simple description) why we chose two antibody fragments instead of having all of full-length them IgGs</p>
        </div>

        <div class="container d-flex flex-column">
            <h3>Plasmid Backbone pSB3K3 with mRFP1</h3>

            <div id="root">
                <script src="{{ url_for('static', filename='seqviz/seqviz.min.js') }}"></script>
        
                <script>
                    var viewer = seqviz.Viewer("root", {
                    name: "Antibody 1 Plasmid",
                    seq: "TAAGGATGATTTCTGGAATTCGCGGCCGCTTCTAGAGCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACATACTAGAGAAAGAGGAGAAATACTAGATGGCTTCCTCCGAAGACGTTATCAAAGAGTTCATGCGTTTCAAAGTTCGTATGGAAGGTTCCGTTAACGGTCACGAGTTCGAAATCGAAGGTGAAGGTGAAGGTCGTCCGTACGAAGGTACCCAGACCGCTAAACTGAAAGTTACCAAAGGTGGTCCGCTGCCGTTCGCTTGGGACATCCTGTCCCCGCAGTTCCAGTACGGTTCCAAAGCTTACGTTAAACACCCGGCTGACATCCCGGACTACCTGAAACTGTCCTTCCCGGAAGGTTTCAAATGGGAACGTGTTATGAACTTCGAAGACGGTGGTGTTGTTACCGTTACCCAGGACTCCTCCCTGCAAGACGGTGAGTTCATCTACAAAGTTAAACTGCGTGGTACCAACTTCCCGTCCGACGGTCCGGTTATGCAGAAAAAAACCATGGGTTGGGAAGCTTCCACCGAACGTATGTACCCGGAAGACGGTGCTCTGAAAGGTGAAATCAAAATGCGTCTGAAACTGAAAGACGGTGGTCACTACGACGCTGAAGTTAAAACCACCTACATGGCTAAAAAACCGGTTCAGCTGCCGGGTGCTTACAAAACCGACATCAAACTGGACATCACCTCCCACAACGAAGACTACACCATCGTTGAACAGTACGAACGTGCTGAAGGTCGTCACTCCACCGGTGCTTAATAACGCTGATAGTGCTAGTGTAGATCGCTACTAGAGCCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCTACTAGAGTCACACTGGCTCACCTTCGGGTGGGCCTTTCTGCGTTTATATACTAGTAGCGGCCGCTGCAGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATCTCGAGTCCCGTCAAGTCAGCGTAATGCTCTGCCAGTGTTACAACCAATTAACCAATTCTGATTAGAAAAACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCGATACCATATTTTTGAAAAAGCCGTTTCTGTAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCGACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCATGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGCTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCAGCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGAGACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACACTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGGGGATCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCATAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACCTTTGCCATGTTTCAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACATTATCGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTGGAGCAAGACGTTTCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGATGATATATTTTTATCTTGTGCAATGTAACATCAGAGATTTTGAGACACAACGTGGCTTTGTTGAATAAATCGAACTTTTGCTGAGTTGAAGGATCAGATCACGCATCTTCCCGACAACGCAGACCGTTCCGTGGCAAAGCAAAAGTTCAAAATCACCAACTGGTCCACCTACAACAAAGCTCTCATCAACCGTGGCTCCCTCACTTTCTGGCTGGATGATGGGGCGATTCAGGCCTGGTATGAGTCAGCAACACCTTCTTCACGAGGCAGACCTCAGCGCTAGCGGAGTGTATACTGGCTTACTATGTTGGCACTGATGAGGGTGTCAGTGAAGTGCTTCATGTGGCAGGAGAAAAAAGGCTGCACCGGTGCGTCAGCAGAATATGTGATACAGGATATATTCCGCTTCCTCGCTCACTGACTCGCTACGCTCGGTCGTTCGACTGCGGCGAGCGGAAATGGCTTACGAACGGGGCGGAGATTTCCTGGAAGATGCCAGGAAGATACTTAACAGGGAAGTGAGAGGGCCGCGGCAAAGCCGTTTTTCCATAGGCTCCGCCCCCTGACAAGCATCACGAAATCTGACGCTCAAATCAGTGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGCGGCTCCCTCGTGCGCTCTCCTGTTCCTGCCTTTCGGTTTACCGGTGTCATTCCGCTGTTATGGCCGCGTTTGTCTCATTCCACGCCTGACACTCAGTTCCGGGTAGGCAGTTCGCTCCAAGCTGGACTGTATGCACGAACCCCCCGTTCAGTCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGAAAGACATGCAAAAGCACCACTGGCAGCAGCCACTGGTAATTGATTTAGAGGAGTTAGTCTTGAAGTCATGCGCCGGTTAAGGCTAAACTGAAAGGACAAGTTTTGGTGACTGCGCTCCTCCAAGCCAGTTACCTCGGTTCAAAGAGTTGGTAGCTCAGAGAACCTTCAAAAAACCGCCCTGCAAGGCGGTTTTTTCGTTTTCAGAGCAAGAGATTACGCGCAGACCAAAACGATCTCAAGAAGATCATCTTATTAAGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTCCATGGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCAGAATTTCAGATAAAAAAAATCCTTAGCTTTCGC",
                    style: { height: "80vh", width: "80vw" },
        
                    annotations:
                        [{ start: 311, end: 988, name: "mRFP1", color: "red", direction: 1 }, // [0, 22)
                    ],
                    })
                    viewer.render();
                    viewer.renderToString();
        
                </script>
            </div>
        </div>

    </div>
    <div class="spacer-div"></div>
</div>

  <!-- SeqViz Stuff -->


{% endblock %}


